scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1024846251 |
P356 | DOI | 10.1038/SREP11099 |
P932 | PMC publication ID | 4650610 |
P698 | PubMed publication ID | 26057697 |
P5875 | ResearchGate publication ID | 279208296 |
P50 | author | Lina Huerta-Saenz | Q59218024 |
P2093 | author name string | Virginia A Stallings | |
Adda Grimberg | |||
Robert Grundmeier | |||
Susmita Pati | |||
Andrew J Cucchiara | |||
Mark Jason Ramos | |||
P2860 | cites work | Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs. | Q51630784 |
Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care. | Q51722103 | ||
National estimates of the timing of sexual maturation and racial differences among US children. | Q52029181 | ||
Growth of Hmong children | Q71857713 | ||
Patient attitudes and preferences regarding treatment: GH therapy for childhood short stature | Q77960054 | ||
Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study | Q79322943 | ||
A national study of physician recommendations to initiate and discontinue growth hormone for short stature | Q84967556 | ||
Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010 | Q29614504 | ||
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee | Q29619180 | ||
Sex-based prevalence of growth faltering in an urban pediatric population | Q33968143 | ||
Sex differences in patients referred for evaluation of poor growth | Q34102453 | ||
Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature | Q34500032 | ||
Medically underserved girls receive less evaluation for short stature | Q34725747 | ||
Socio-economic status and z-score standardized height-for-age of U.S.-born children (ages 2-6). | Q35032646 | ||
Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®. | Q35200538 | ||
Effects of obesity on growth and puberty | Q36252470 | ||
Gender of pediatric recombinant human growth hormone recipients in the United States and globally. | Q36732668 | ||
Nutritional stunting. | Q36841486 | ||
Growth patterns of first-generation Southeast Asian Americans from birth to 5 years of age. | Q39433882 | ||
Pedigree analysis of constitutional delay of growth and maturation: determination of familial aggregation and inheritance patterns | Q40617538 | ||
Short stature and growth hormone therapy. A national study of physician recommendation patterns | Q40930280 | ||
Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children | Q43443303 | ||
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency | Q43767399 | ||
The influence of secular trend for height on ascertainment and eligibility for growth hormone treatment | Q44541281 | ||
Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program. | Q45991299 | ||
Trends in the associations between family income, height and body mass index in US children and adolescents: 1971-1980 and 1999-2008. | Q46119081 | ||
Genetic and environmental determinants of growth in Mexican-Americans | Q46193889 | ||
Long-term safety of recombinant human growth hormone in children | Q46198179 | ||
Differences in the physical growth of US-born black and white children and adolescents ages 2-19, born 1942-2002. | Q46754015 | ||
Height of US-born non-Hispanic children and adolescents ages 2-19, born 1942-2002 in the NHANES samples | Q46946827 | ||
Growth status among low-income Mexican and Mexican-American elementary school children. | Q47187166 | ||
Height at 2 and 5 years of age in children born very preterm: the EPIPAGE study | Q47395818 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bias | Q742736 |
gender bias | Q1501326 | ||
P304 | page(s) | 11099 | |
P577 | publication date | 2015-06-09 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Gender Bias in U.S. Pediatric Growth Hormone Treatment | |
P478 | volume | 5 |
Q38681742 | Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence |
Q41557010 | Parental Concerns Influencing Decisions to Seek Medical Care for a Child's Short Stature |
Q89033545 | Race and gender influence management of humerus shaft fractures |
Q35859413 | Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes |
Q59812967 | Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care |
Q47555739 | Short Stature Diagnosis and Referral |